{"name":"Kestrel Therapeutics, Inc.","slug":"kestrel-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxQcmdpaTZ2Qlo0RUViZDR4bHJiY3BnZVo0RUZxaVhpc0FGZ1dZVEphUnpYbFVCQVhqVEkyU1ZSbVJkRXRzVGpKQ1FaRTNfd1ZGUjVGVE1rTzVBLU1nOTJvMHZFc0g5RWh4Q0VtTWpCZFJZdGVzZTJGVXpTZE1nQkJFbXVQYnRUVmVscGxJc1QxQlBhYlJZTEQ0UEpzZDczZWFhVTZtbXIyMnpPNWl1RlBuRDI2VllfVUNPRTNPcHBFR2JQREdycmZhdTlrdUVfTGp2OWdhSFhzZGJmMkpOaFNndEdyOElEVi1vMlozVHViMF9BM2FmclhVeDAzaVNnR25URjA2b3NabUdHcU5pdlNQRUg4eTVNUXZfN2lMWlpFejFIZFN3RFN2TnFSSWtvcnJ6OWlSM0pFT1FqOWxOdXM0cm5Raw?oc=5","date":"2026-03-05","type":"regulatory","source":"GlobeNewswire","summary":"Kestrel Therapeutics Announces IND Clearance by U.S. FDA of - GlobeNewswire","headline":"Kestrel Therapeutics Announces IND Clearance by U.S. FDA of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9RZHVhZWJfUzNfclQxRHJ6TjEzVkkxTG1NZUVqQU9ycnVMREdVVG5TcFVGS0JiaFhSMGpVR1FPeTNENXJER29YY3hIVVo2djJwRk5LZnB5blJmdHJK?oc=5","date":"2026-01-20","type":"pipeline","source":"EurekAlert!","summary":"Hollings researchers reveal why some pancreatic tumors behave differently - EurekAlert!","headline":"Hollings researchers reveal why some pancreatic tumors behave differently - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"Nature","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - Nature","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPbGJtcGFGWnRCVFppQ3JIdEphMDhGbzdJbzhNbWJSWlBzcmt1Y3FLbEpjclJENnRTMi15ZHBYTk8zNHBtMFBnSzB5TzBZM1JnRkQ1SUZyZnVCTUl2UXp5M3NscmJsVUhmTS1mc2dTRm5yT1NqVGFwdGlPTUMtUVFwMUlrTENpcURSS1Zpclg0UGdyQy03Z2xsaHN2SnhRLTg?oc=5","date":"2025-07-02","type":"pipeline","source":"BioWorld News","summary":"Kestrel Therapeutics describes new GTPase KRAS inhibitors - BioWorld News","headline":"Kestrel Therapeutics describes new GTPase KRAS inhibitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQVTF2eXE4djVWcWJnZHF2eUxPcUVFSkNGTjVwRjJYcHJVeUhvYlIyNzQ1Sm9YM2FaZ0U3ZWZmNWZub0wweGNIcDVGZWNUQWppWTdiV1dLQnJBQXJKMzVyNmdUNXI3cnBPeGlyUmhqSWhJRmxQOXRpLWtJaDJPRGpISTZRcTVVZi1neEE?oc=5","date":"2025-06-16","type":"pipeline","source":"Cancer Therapy Advisor","summary":"ASCO 2025: Advances in Colorectal Cancer - Cancer Therapy Advisor","headline":"ASCO 2025: Advances in Colorectal Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFBXdzdGSGtrWm9HcVFQQlV4TGx1aTFZdEZacjVYNFRpUVctQVlESXlIRmNsbFQzZEk3WlJPWGlXRmkwT2g1b0Zkb2x6YnlGQ2dFM3QwWTdfVmV4Z09MYm1aVHFVcjV1dUFjX1UzRS1iUUxFZE0?oc=5","date":"2022-06-02","type":"pipeline","source":"Auburn University","summary":"Diverse drug discovery team brings decades of experience to fight against deadly disease - Auburn University","headline":"Diverse drug discovery team brings decades of experience to fight against deadly disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPQzVYakJycmJUcEo3TlRKOGQ2OUVCajl4bFR3ZFQ4cS16MlZLcXZpM1RUUjk4cXVLNVVBanlGMHgtZkhOaUhXSE1PLUNva0JoWXdXNjhuYzhpVnhxZ2RobHlBSzR3UHR6MTQzUmlRM3NKM0J1UVRKVmZHOHJYUVh0alN6S18wSnE0TkE0bzZKX1dINnoxcmExTW9PZURrSGQ2Q0doNmRzVVcyUG1NOTlWYWlwbnhDVmNjRXo0VktiOXFDdms2QjFQaDZsNzNiclJwZU9zVEdn?oc=5","date":"2021-12-09","type":"regulatory","source":"Novartis","summary":"Novartis announces positive results from year two of the Phase III trial of Beovu® in diabetic macular edema - Novartis","headline":"Novartis announces positive results from year two of the Phase III trial of Beovu® in diabetic macular edema","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNdE1kVVpxeUlxS3NNVDhKTkVXR3dmb0V4eG1QV2Nud3RyaFV3UlBCVXBVT2hfWjF4SktScEViM3U5UmtFOFJrcVdVdGYzVEZCMk1IbkZzc2c5NUgyUG1oX0ZFLVVEUmw4ajRXdTBibjRKYmNZYWU2Z2ktdjNmbTZfaVhhTmRXR2QxTV9ZQXBYR0lYRVpxYVhycVd2S2Z4LVpKckJBYmNhTFgyU0Jo?oc=5","date":"2021-03-16","type":"deal","source":"prnewswire.com","summary":"Chemomab Completes Merger with Anchiano Therapeutics - prnewswire.com","headline":"Chemomab Completes Merger with Anchiano Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}